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invitations and other mailings of interest are sent to them 
periodicallv. Services are a\'ailable for the wives and families 
of these foreign phniciar.s. We ha\'e 31so instituted an annu-
al series of 5vmoosia" for directors of medical education. 
hospital directors'. chiefs 'J! services and others responsible 
for foreign house staff. T;l<:se symposia cover various aspects 
of the problems inmhed "'i!h foreign medical graduates. 
and attempt to prO\'ide a (or:Jm for the exchange of ide:ls 
and information :lmong those who come in closest contact 
with them. 
The Philadelphia pro'Fam has deve!oped from close co-
operation between the medical community and lay organiza-
tions interested in service to foreign visitors. We hope it will 
become a prototype for the development of similar pro-
grams in other pans of .h-: WU!HrY. 
Philadelphia. P:l. 
.-\LTOX I. SCT:"ICK. ~I.D. 
Institute for Cancer Research 
Fox Chase 
1. Sutnick AI: Th<! trainee from abroad. Ann Intern .\led 68:11:7· 
1128.1968 
2. Idem: Med:.:al ambassadors. Area Environ Health \Chi~3go) 18:4-
6.1969 
3. Idem: Firs! symposium on ,he probiems of foreIgn medical gradu-
ates. JA\IA (in press) 
IMMt;:\OSt.:PPRESSIO:-; A:\D ~L\LIG:\A:\T 
:\EOPL\S\IS 
To Ih~ Editor: Simmons and his associates (~ew Eng J \'[ed 
283: 190-191. 19iOl have taken a position against the discon-
tinuance or lightening of immunosuppressive therapy in 
organ-homograft recipients in whom de novo cancers ha\'e 
developed. Their argument is based almost entirely on ob-
servations of a patient who actually did stop steroid therapv 
toward the end of her life. who then displayed evidence of 
recovered immunological reactivity by promptly rejecting her 
renal homograft. which had hitherto been functioning for 
four years. and who died 16 months after the diagnosis of 
disseminated dysgerminoma had been made. At autopsy. re-
sidual tumor could not be found. Leaving aside the question 
of how effecth'eiy the patient had reduced her own immuno-
suppression. the term "cure" of a cancer as it appe3rs in the 
title should be questioned even in an immunologically com-
petent person after so short a follow-up period. 
Since the first description of de novo malignant neoplasms 
in renal-homograft recipients in 19681." there have been 010 
known cases of this complication. of which 11 ha\'e been in 
our institutions. The 101 patients with superficially located 
epithelial neoplasms (skin. lip and uterine cervix) were all 
effectively treated by standard surgical technics without risk-
ing the homografts by reductions in immunosuppression. 
Even in such cases. the neoplasms may present special prob-
lems since one of our kidney recipients, 41 years of age, has 
already had three squamous-cell carcinomas of the skin 
removed in his 71h years of post-transplantation life. 
The epithelial tumors within the abdomen and chest and 
the mesenchvmal cancers in all locations have not been con-
trolled with this approach: eight of nine "deep" carcinomas 
and 16 of I'; :ne,ench\mai tumors h,,·. e leu or cOlHributt:u 
to early death. The exceptional patient in the deep epithelial 
group was the one described by Simmons et aI., and since 
she died, it can:]'"'t be est4blished for ce'[:J.in what the natu-
ral behavior of the dYsgerminoma might have been. The 
surviving patie:1t in the mesenchymal group was treated at 
our center bv radiotherapy of her braimtem lymphoma 212 
years ago. in addition LO a drastic reduction in immuno-
suppression. Details of all 010 patients from throughout the 
world in whom malignant neoplasms ha\'e developed in the 
post-transplantation period are being published3 •• and will be 
provided upon request . 
It mav be that the conte:;til)f1~ of Simmons et al. will ult:. 
mateh prove to be corree:. Howe\er. it is worth noting that 
the pre~ent evice!lce h)::1 our international compilat:ol: 
does nnt IUpport :heir p'"sitiGll. and th:lt their argum~nts 
are based upon a case t:~~: ,I} ,'af is not unl\' nonreprest'nta. 
tive but uniquely ii). Cor.5esu/:miv. it seems reasonable not 
to dismiss so fC:_C::;' J.S :.~;;': ;]a\e done the possibilit:: of 
lightening immu::cm:Jsre;;:'-'n in ?atients with post-trans. 
plantation carcir.u::::,s 3.r.::: :-;~pholllas. 
Denver. CuI. 
THo~IAs E. STARZL, ~r.D. 
Proji'ssor oj 5111"6;''' 
ISRAEL PE.'\S. ~!.D. 
.-t,,\'ociale Professor (~lSllrgf'ry 
C:I.~RU:S C. H.\LGRl~ISOX. ~.r.D . 
. I \\-i_\/a f.' ( P "",';'\\(1" Ill' '~"/;: .. ,~, 
Department'of SUf':ren-
t: d\·e~slt\· of Colorado ~Iedicai C:';;te~ 
I. Starzl TE: Discussion cf ~[urray JE. Wilson RE. T;iney :-OL. et 
al: Five years' e.~pehen"e 'n renal transpiantation ">1Ih immuno-
suppressive drugs: sUf\waL function. comp!i.::ltions. and the role 
of lymphocyte depletion ~:. 'haracic duct fistula. Ann Surg 168: 
411i . .19.68 
, Peiit?i. Hammond W. Bre::schneider L. ~t al: :-'bllgnant Iympho· 
mas in transplantation patients. Transplantation Pro<: 1:106. 1969 
3. S::lrz! TE. Porter K.-\. H,,;m:mon CG. et a!: LanS! !e~m S',rV;,""! 
after renal transplantation ,; humans: with special reference to his-
tocompatibility matching. :h\ mectomv. h,'mograft glomerulo· 
nephritis. heterOlogous .... LG. an.:i recipient malignancy. Ann Surg 
17:: September. 1970 
4. Penn I. Halgrimson eG. S!.lrzl TE: De /101"0 malignant tumors in 
organ transplant recipients. Tr~nsplantation Proc (in press) 
The above letter was reierred to the authors of the article 
in question. two of whom offer the following reply: 
To til, Editor: For a number of reasons. we consider it un-
tikel~' that transplanted patients in whom de nom malignant 
neoplasms develop will reject their tumors if immunosup-
pression is stopped. In cht! first place. although all experi-
mental tumors induced bv viruses or chemical carcinogens 
have tumor antigens. such antigens have been difficult to 
detect on tumors that are "spontaneous.'" Secondly. even 
when such antigens have been found. they are poor immu-
nogens as compared with the histocompatibility antigens 
normally responsible for ailograft rejection. Thirdlv. the vig-
or of rejection is directh' proportional to the strength of the 
immunogenic stimulus .. -\nd. finally. tumors with weak anti-
gens. even when known to be immunogenic. may be self 
enhancing - that is. antibodies are elicited that do not lead 
to the rejection of the tumor but to its further growth. l For 
these reasons. tumors that are transplanted inadvertently 
from the donor to the recipient possess the strong histocom-
patibility antigens of the donor and will be rejected upon 
cessation of the immunosuppression.- Spontaneous tumors 
with we3k or absent immunogens that are well enhanced are 
not likely to be rejected when immunosuppression is 
stopped. Certainly. the kidney will be rejected first. Thus. to 
hope that a drastic reduction in immunosuppression will al-
low the patient to reject the tumor without rejecting the 
kidney is probably futile. The patient with a tumor but with-
out a good. functioning i.:idnev is certainly at a ~reat disad-
vantage. 
Thus, we believe Str~He~y for this rare complic3!ion is con-
ventiollJ.l therapY direc:ed toward ublite,ating the tumor 
without altering the existin~ immunologic balance. The p3-
tient discussed had InJ.::;;'e5[ed four severe reml rejection 
episodes during her post-transplant course. Thus. when sht! 
stopped taking prednisone for one month (but maintained 
herself on azathioprine). the kidney was rejected. It is un-
likely that the brief period of partial immunological rebound 
led to the compltu obliteration of all traces of the tumor. 
The Denver patient. on the other hand. did not n!m reject 
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her 'kidney when immunosuppression was stopped, and it is 
iikdy that her remission was due to the radiotherapy alone. 
We agree with the following points of the Denver group: 
the patient may not have been "cured," but no remnant of 
tumor was present at death; epithelial neoplasms can be 
treated by standard therapy without endangering the al1o~ 
graft; and we must reserve judgment in the treatment of 
"deep" tumors. The tentative nature of our conclusions is 
reflected in the concluding paragraph, in which the words 
I "possible", "one would not expect" and "probably" are used. I -Starzl and his co-workers have made the greatest contribu-i -"':-tion to this field. We apologize for inadvertently omitting reference to their published paper (reference 2 in the above letter). 
'~'~l'J- RICHARD L. SIMMONS, M.D. 
Associate Pmfessor of Surgery alld Microbi%g)' 
-: .... 
JOHN S. :'\AJARlAN, M.D. 
Profwor alld Chairman of Surgery' 
Depanment of Surgery 
University of Minnesota 
:....Minneapolis, Minn. 
r~cKhann CF: Immunobiology of cancer. Transplantation. Edited 
by JS Najarian. RL Simmons, Philadelphia. Lea and Febiger (in 
press) 
2. Hellstrom IE. Hellstrom KE. E\'ans CA. et al: Serum mediated 
_ ' protection of neoplastic cells from inhibition by lymphocytes im-
I murie to their tumor-specific antis ens. Proc Nat Acad Sci V SA 
'
1 i' 62:362·368. 1969 
i, 3. Wilson RE. Hager EB. Hampers CL. et al: Immunologic rejection 
of human cancer transplanted with renal allograft. New Eng J Med 
278:479-483. 1968 
\~~-
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MELANOMA·SPECIFIC ANTIGE!,\S 
,To the Editor: The recent article of Jehn et al. on 
melanoma-specific antigens C'\ew Eng J Med 283:329·333. 
1970) was both very interesting and disturbing to me. First 
of all, the number of patients 2?parently sensitized to the 
tumor extracts is exceedinglY hizh (s{'Yen of se\'en), I should 
therefore like to know if the au,h0rs chose to present only 
macting patients and. if so. the w:.c.: number of patients with 
melanoma studied. 
Secondlv. as a control to exclude definitely tumor-unre-
lated reactinns. I bdicI'e that si::.::_~ ("::racts from normal 
skin tissue or benign plgmenrec lesions should ha\'e been 
tested as possible mitol\'enic all'en:s. \\'ere these experiments 
~'me', and \\"hat "'"ere their re5'..l::~~ 
Finally. a brief comment Oil ,1. t :-~l{'vance of intracellular 
'-lTIUS rr.embrane-Iocated It:r.,~ -"Jecific antigens to the 
host's immune response ill \ 1\1'; :tid ue appreciated. 
il'ILLY F, PIESSE'-:S. \!.D. 
\[2.s,~,husetts General Huspital 
rile abm-e letter \\,lS retcrred, :;,e authOl's of the article: 
In question. t,,-o of ,,-hom "fi'er :'~c idl",,-i!l[!, replv: 
h II" Edit",.: To anSher Dr. P:t"'_'lS'S questions in order. 
-. :he first pi;,ce_ :i:; re was nn 'e:','c:'on: Se\'ell consecutive 
~J.tlt'rlt5 \\':?re s~a(:lCd .. \Il P;l;:V.·· ::::d nlet~st~tic disease ;!nd 
"~ tXten, of l:lei:- (:i;e'lse Y:'!'ltG ::-{Hl1 r-e!!,ional-Ivmph-node 
:: "(';'emem to rlistant \-i,ceral n:t:ast3'CS. 'JlIdg-in~ from Ihe 
-': ,::'" f)fE,ti"midine upLake b', L_"ir l\'tnphocnes. 110t all 
,' .. -'" ',' '.Te <~Ilsitized to tile S2::.e ci·:C!'l·"e. 
; ~<.::-.:)r!iy. \I-e did nOl measure ;', ::lphoc\'te transformation t ,:!le presence of tissue extract-' :~om a benign pigmented 
~l(Jn. 
Finallv. we did not stud" intrace;i'.:!;.:~ a:ld membrane anti-
j~~s. This has been done 'by Le\':s ~: :::. (Brit \Ied J 3:5-i7. 
09). It seems to u~ that mer::b~;lne aIlligens might be 
more important than intracellular antigens in the postulated 
immunologic defense mechanisms against malignant cells. 
LARRY ~ATHANSON. M.D. 
ROBERT S. SCHWARTZ, M.D. 
Depanment of ~[edicine 
New England Medical Center Hospitals 
Boston. Mass. 
CORRELA TION OF THYROID-FUNCTION 
STUDIES 
To the Editor: The last 10 years have seen the development 
of several new tests of thyroid function. This proliferation of 
examinations has confronted the physician with the difficult 
decision of selecting the test that will give him the most 
meaningful and accurate data. , 
It is generally recognized that in the absence of contami-
nation with iodine or other drugs, the uptake of 131 1 by the 
thyroid gland has a diagnostic accuracy of 83 per cent for 
hyperthyroid and 73 per cent for hypoth'Toid patients. The 
measurement of serum thyroxine by competitive protein 
binding has an accuracy of 90 per cent in both conditions.' 
The uptake of 131 I is a measure of the iodine-trapping 
ability of the gland, whereas the determination of serum 
thyroxine by competitive protein binding is a measure of 
circulating thyroid hormone.:·3 In spite of measurements of 
different aspects of thyroid function, there appears to be a 
high degree of correlation between these tWO examinations. 
In an attempt to demonstrate this relation, 140 patients were 
studied. of whom six were hypothyroid, 29 euthyroid, and 
105 hyperthyroid. 
Of these patients the average serum th)Toxine level was 
22.16 I'g per 100 ml in the hypenhnoid group, 8.67 I'g per 
100 ml in the euthyroid group and 2.3 I'g per 100 rnl in the 
hypothyroid group. 
The 1"1 I uptake among the h\'perthyroid patients averaged 
57 per cent: in the euthyroid group the value was 25 per 
cent. and the hYpothyroid patients had an uptake average of 
6 per cent. 
The correlation coefficient for the h\'pothyroid group was 
0.91. whereas for the hyperthHold patients. the value was 
0.86 and for the euthyroid patients. the coefficient was 0.88. 
The correlation coefficient for the entire series of 140 pa-
tients was 0.88. 
By using the~e t\\'o tests in e\'aluating the patient with 
suspected th\Toid disease. the clinician can feel confident 
that he is using the examinations that not only yield the 
highest degree of accuracy bUl also I'efiect a significant de-
gree of correlation. 
Gaines\-ille. Fla. 
ROBERT 7\lILLER. ~!.D. 
Di\'ision of Endocrinology 
Dep.1nment of 7\ledicine 
L :li\'ersitl of Florida 
':._,):e;:;e :,r \kdicine 
L Ashkar FS. Gij,on A. ~l"de :'I.: Gr",e, Dise.::,e - Diagnosis and 
Treatment -.; ~fono~rarh, \li27.i, l'ni\-er"t) of \!iami. 1970. 
p 3 
Ingbar SH. Woet-~r K,-\: The thyroid ~"'n':. Textbook of Endocri-
nelogy, Edited b\ Ri-l Wilh"ms, Pniladeipnl_. WB Saunders Com-
p.in\,. lY68. rr 1~:-16: 
3, \lurphy BEP. P •. ::~e CJ: Determl~a:i,,~ <':- :eym>.ine utilizing the 
propeny of pwtel:l·(-mdin;:. J elir. E~docr :":1~7-196. 1'164 
\T:-.';'\[L\ PREP .. \R.!.,TLJ'-::; FOR 
PATIE'-:TS \\,ITH P.\Rhl'-:SO'-:IS~1 
Te' lite Idi/"r: Parkinsonism "nd pe!':l!~ioUS :memia are 
both diseases of late adult life. The e;:lCl ;J:-e\alcnce of these 
diseases is unkno\\·n. but a reasonable e;!imare would be 
approximately 100 per 100.000.": Doses of vitamin B" of 
r 
